PB2125: VCD VERSUS VRD‐BASED REGIMENS AS INDUCTION THERAPIES IN PATIENTS WITH PRIMARY MULTIPLE MYELOMA (MM): HIGHLIGHTING STRATEGIES THAT ACTUALLY WORK.

• Olga Novosad,
• Irina Kriachok,
• Tymur Rudiuk,
• Ian Pastushenko,
• Iryna Tytorenko,
• Olena Aleksik,
• Natalia Shudrak,
• Tetiana Kadnikova,
• Olexandr Horbach,
• Ulyana Melnyk,
• Larysa Mykhalska,
• Yana Stepanishyna,
• Nazar Shokun

Affiliations

Olga Novosad

1 IOSI, EOC, Hematology, Bellinzona, Switzerland

Irina Kriachok

2 NCI, Hematology, Kiev, Ukraine

Tymur Rudiuk

2 NCI, Hematology, Kiev, Ukraine

Ian Pastushenko

2 NCI, Hematology, Kiev, Ukraine

Iryna Tytorenko

2 NCI, Hematology, Kiev, Ukraine

Olena Aleksik

2 NCI, Hematology, Kiev, Ukraine

Natalia Shudrak

2 NCI, Hematology, Kiev, Ukraine

Tetiana Kadnikova

2 NCI, Hematology, Kiev, Ukraine

Olexandr Horbach

2 NCI, Hematology, Kiev, Ukraine

Ulyana Melnyk

3 City Hospital №9, Hematology, Kiev, Ukraine

Larysa Mykhalska

4 Clinical Hospital Feofania, Center for Hematology, Chemotherapy of Hemoblastoses and Radiation Therapy, Kiev, Ukraine

Yana Stepanishyna

5 NCI, BMT Unit, Kiev, Ukraine

Nazar Shokun

5 NCI, BMT Unit, Kiev, Ukraine